FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the use of the compound L- ascorbatoriboflavinatovanadyl(II) teisemihydrate(1) (C23H26N4O13V·3.5H2O) in dosage 50-150 mg/kg when applied in animals as an antihypoxant drug.
EFFECT: invention provides prolonged lifespan in animals in acute exogenous hypoxia, decreases rectal temperature and animal's oxygen requirement.
7 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
3-(N,N-DIMETHYLCARBAMOYLHYDROXY)-2-ETHYL-6-METHYLPYRIDINE SUCCINATE SHOWING ANTIHYPOXIC ACTIVITY | 1993 |
|
RU2095350C1 |
DRUG EXHIBITING ANTIHYPOXIC ACTIVITY | 2022 |
|
RU2809486C2 |
1-ALLYLIMIDAZOLE DERIVATIVES | 2009 |
|
RU2430090C2 |
2-AMINOBENZOTHIAZOLE DERIVATIVES, HAVING ANTI-HYPOXIC ACTIVITY AND METHOD OF USING SAID DERIVATIVES | 2010 |
|
RU2448100C1 |
DRUG WITH ANTIHYPOXIC, ANTIAMNESTIC AND NEUROPROTECTIVE ACTIVITY | 2020 |
|
RU2750418C1 |
NEUROTROPIC AGENT WITH ANTIOXIDANT, ANTIHYPOXIC, NEUROPROTECTOR, ANTIAMNESIC AND ANTI-MOTION SICKNESS ACTIVITY AND CAPABLE OF ENHANCING COGNITIVE FUNCTIONS | 2008 |
|
RU2394816C1 |
APPLICATION OF 7-BROMOMIDAZO [4,5-B] INDOLE-2-THYONE FOR PROTECTION OF ORGANISM AGAINST INFLUENCE OF HYPOBARIC, HEMIC AND HYPERCAPNIC HYPOXIA | 2005 |
|
RU2340341C2 |
ANTIHYPOXANT AND METHOD FOR PREPARING IT | 2013 |
|
RU2506074C1 |
ANTIHYPOXIC AGENT | 2001 |
|
RU2213571C2 |
1-ALKENYLIMIDAZOLE DERIVATIVES | 2008 |
|
RU2397175C1 |
Authors
Dates
2012-09-20—Published
2011-05-25—Filed